DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,372 | -1.9% | 78,082 | -5.1% | 0.24% | +4.3% |
| Q2 2023 | $19,748 | -13.2% | 82,287 | -8.9% | 0.24% | -13.0% |
| Q1 2023 | $22,758 | -6.5% | 90,298 | -1.5% | 0.27% | -10.9% |
| Q4 2022 | $24,340 | -99.9% | 91,707 | +0.9% | 0.30% | -3.8% |
| Q3 2022 | $23,468,000 | -0.4% | 90,862 | -2.2% | 0.32% | +9.4% |
| Q2 2022 | $23,565,000 | -10.2% | 92,952 | +3.8% | 0.29% | +4.3% |
| Q1 2022 | $26,255,000 | -13.3% | 89,507 | -2.8% | 0.28% | -5.5% |
| Q4 2021 | $30,286,000 | +2.0% | 92,052 | -5.6% | 0.29% | -2.0% |
| Q3 2021 | $29,686,000 | +12.2% | 97,512 | -1.1% | 0.30% | +11.2% |
| Q2 2021 | $26,460,000 | +18.4% | 98,602 | -0.7% | 0.27% | +10.3% |
| Q1 2021 | $22,340,000 | -2.1% | 99,257 | -3.4% | 0.24% | -6.2% |
| Q4 2020 | $22,820,000 | -1.6% | 102,729 | -4.6% | 0.26% | -9.4% |
| Q3 2020 | $23,183,000 | -4.3% | 107,666 | -21.4% | 0.29% | -7.7% |
| Q2 2020 | $24,228,000 | +16.5% | 137,017 | -8.8% | 0.31% | -5.8% |
| Q1 2020 | $20,789,000 | -4.3% | 150,205 | +6.1% | 0.33% | +15.8% |
| Q4 2019 | $21,720,000 | -1.9% | 141,527 | -7.7% | 0.28% | -5.0% |
| Q3 2019 | $22,137,000 | +75.4% | 153,283 | +73.6% | 0.30% | +41.0% |
| Q2 2019 | $12,618,000 | +6.2% | 88,299 | -1.9% | 0.21% | +1.0% |
| Q1 2019 | $11,884,000 | +19.6% | 90,031 | -6.6% | 0.21% | +9.4% |
| Q4 2018 | $9,939,000 | -4.0% | 96,398 | +1.2% | 0.19% | +10.3% |
| Q3 2018 | $10,353,000 | +11.4% | 95,289 | +1.1% | 0.17% | +4.8% |
| Q2 2018 | $9,297,000 | +11.8% | 94,234 | +11.0% | 0.17% | -4.0% |
| Q1 2018 | $8,313,000 | +34.3% | 84,924 | +27.3% | 0.17% | +16.9% |
| Q4 2017 | $6,192,000 | +321.5% | 66,724 | +289.6% | 0.15% | +97.3% |
| Q3 2017 | $1,469,000 | -3.0% | 17,128 | -4.6% | 0.08% | -27.2% |
| Q2 2017 | $1,514,000 | +2.6% | 17,958 | +3.9% | 0.10% | -4.6% |
| Q1 2017 | $1,476,000 | +55.2% | 17,278 | +41.4% | 0.11% | +18.7% |
| Q4 2016 | $951,000 | – | 12,220 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |